- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
New Wuxi Life Science Ltd.
BioCentury | Oct 1, 2021
Finance
From NASDAQ to $120M series A, CBMG readies for next phase
Megaround for cross-border cell therapy company follows privatization led by Tony Liu
BioCentury | Dec 14, 2018
Financial News
WuXi AppTec unchanged in first day of trading on Hong Kong exchange
BioCentury | Oct 11, 2018
Strategy
Border security for China’s genomes
Balancing protection and translation for China’s genomic data troves
BioCentury | Sep 21, 2018
Finance
Funding WuXi’s expansion
Hong Kong stock listing could fuel WuXi AppTec’s continued growth
BioCentury | Sep 21, 2018
Product R&D
China’s rising genomics start-ups
How Chinese start-ups are going big on the genome
BioCentury | Jun 2, 2018
Strategy
Partnering on a mission
How Brii’s partnering strategy benefits investors and Chinese social good
BioCentury | Apr 6, 2018
Finance
China’s exchange options
Comparing fast track pilot for mainland China listings to revamped HKEX
Items per page:
1 - 10 of 70